Literature DB >> 16368215

Subacute sclerosing panencephalitis surveillance study in Istanbul.

Ayse Emel Onal1, Candan Gurses, Guher Saruhan Direskeneli, Gulden Yilmaz, Veysi Demirbilek, Sibel Penbe Yentur, Sevda Ozel, Zuhal Yapici, Yildiz Tumerdem, Aysen Gökyigit.   

Abstract

The exact incidence rate of subacute sclerosing panencephalitis (SSPE) in Turkey (and in Istanbul) is not known. We have conducted an active surveillance study to determine the epidemiological characteristics and the incidence rate of SSPE in Istanbul between the dates July 1, 2002 and July 1, 2004. We found that the incidence of SSPE in Istanbul is 2 per million. By logistic regression analysis, risk factors in SSPE development are determined as being at younger ages (OR: 1.199, 95%CI=1.047-1.372, P=0.009), living in crowded households (OR: 1.430, 95%CI=1.039-1.968, P=0.028), low education level of the mother (OR: 0.123, 95%CI=0.034-0.447, P=0.001), low household income (OR: 0.413, 95%CI=0.234-0.728, P=0.002), infant's being born out of Marmara region (Istanbul is in Marmara region of Turkey) (OR: 0.358, 95%CI: 0.172-0.746, P=0.006), infant's not being vaccinated against measles (OR: 0.495, 95%CI: 0.312-0.786), infant's having had measles before (OR: 0.235, 95%CI: 0.135-0.411). As a result, it is found in this study that SSPE is mostly related to having measles infection, and measles vaccination is found to be highly protective against SSPE. This is the first epidemiological study in SSPE from Turkey that conveys the incidence rate in Istanbul.

Entities:  

Mesh:

Year:  2005        PMID: 16368215     DOI: 10.1016/j.braindev.2005.07.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  An evaluation of subacute sclerosing panencephalitis patients with diffusion-weighted magnetic resonance imaging.

Authors:  M Abuhandan; H Cece; M Calik; E Karakas; F Dogan; O Karakas
Journal:  Clin Neuroradiol       Date:  2012-08-12       Impact factor: 3.649

2.  Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Vuslat Yilmaz; Veysi Demirbilek; Candan Gürses; Sibel P Yentür; Serap Uysal; Zuhal Yapici; Gülden Yilmaz; Aaron Muncey; Ozlem Cokar; Emel Onal; Aysen Gökyiğit; Güher Saruhan-Direskeneli
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

3.  Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus.

Authors:  Sibel P Yentür; Veysi Demirbilek; Candan Gurses; Safa Baris; Umit Kuru; Semih Ayta; Zuhal Yapici; Suzan Adin-Cinar; Serap Uysal; Gulden Celik Yilmaz; Emel Onal; Ozlem Cokar; Güher Saruhan-Direskeneli
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

Review 4.  Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas.

Authors:  Pauline Samia; Katherine Oyieke; Dorcas Tunje; Anaita Udwadia-Hegde; Kristen Feemster; Ibrahim Oncel; Banu Anlar
Journal:  Curr Treat Options Neurol       Date:  2022-03-19       Impact factor: 3.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.